COX2 induction: a mechanism of endocrine breast cancer resistance?
Sign Up to like & getrecommendations! Published in 2017 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-017-4284-7
Abstract: PurposeUrine prostaglandin E2 (PGE2) levels have shown to be a risk factor of breast cancer, and the use of nonsteroidal anti-inflammatory drugs (NSAIDs) is known to be beneficial in preventing breast cancer risk and/or recurrence… read more here.
Keywords: cox2 induction; pge2; pge2 levels; breast cancer ... See more keywords